AMBISOME: payments to doctors
Payments that named AMBISOME as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $145K
- Providers
- 818
- Transactions
- 1,838
- Average per transaction
- $79
The per-transaction average — $79 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 818 providers the average total is $177, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Gilead | $74,766 | 51.5% |
| Astellas Pharma US Inc | $70,322 | 48.5% |
| Astellas Pharma Global Development | $14 | 0.0% |